J Donze

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model
    Jacques Donzé
    Division of General Medicine and Primary Care, Brigham andWomen s Hospital, Boston, MA 02120, USA
    JAMA Intern Med 173:632-8. 2013
  2. doi Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Thromb Res 131:502-7. 2013
  3. doi Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Am J Med 125:1095-102. 2012
  4. doi Risk of falls and major bleeds in patients on oral anticoagulation therapy
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Am J Med 125:773-8. 2012
  5. doi Prognostic importance of anaemia in patients with acute pulmonary embolism
    Jacques Donzé
    Division of General Internal Medicine, University of Lausanne, Lausanne, Switzerland
    Thromb Haemost 106:289-95. 2011

Detail Information

Publications5

  1. doi Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model
    Jacques Donzé
    Division of General Medicine and Primary Care, Brigham andWomen s Hospital, Boston, MA 02120, USA
    JAMA Intern Med 173:632-8. 2013
    ..Because effective interventions to reduce hospital readmissions are often expensive to implement, a score to predict potentially avoidable readmissions may help target the patients most likely to benefit...
  2. doi Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Thromb Res 131:502-7. 2013
    ..We aimed to prospectively evaluate whether unselected medical patients on oral anticoagulation have an increased risk of bleeding when on concomitant antiplatelet therapy...
  3. doi Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Am J Med 125:1095-102. 2012
    ..We aimed to externally validate and compare the prognostic performance of 7 clinical prediction scores for major bleeding events during oral anticoagulation therapy...
  4. doi Risk of falls and major bleeds in patients on oral anticoagulation therapy
    Jacques Donzé
    Division of General Internal Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
    Am J Med 125:773-8. 2012
    ..We aimed to evaluate whether patients on oral anticoagulation with high falls risk have an increased risk of major bleeding...
  5. doi Prognostic importance of anaemia in patients with acute pulmonary embolism
    Jacques Donzé
    Division of General Internal Medicine, University of Lausanne, Lausanne, Switzerland
    Thromb Haemost 106:289-95. 2011
    ..82, 95% CI: 1.60-2.06) and a decreased odds of discharge (OR 0.85, 95% CI: 0.82-0.89). Anaemia is very common in patients presenting with PE and is independently associated with an increased short-term mortality and length of stay...